Welcome to our dedicated page for Leidos Holdings news (Ticker: LDOS), a resource for investors and traders seeking the latest updates and insights on Leidos Holdings stock.
Leidos Holdings, Inc. (NYSE: LDOS) delivers mission-critical technology and engineering solutions to defense, intelligence, and healthcare sectors. This news hub provides investors with essential updates about contract awards, strategic partnerships, and operational developments impacting this Fortune 500 leader.
Access timely press releases and analysis covering Leidos' defense modernization initiatives, cybersecurity advancements, and health IT innovations. Our curated collection helps stakeholders track progress in key areas like geospatial intelligence, digital transformation projects, and government contracting milestones.
Find updates on quarterly earnings, major Department of Defense contracts, and research breakthroughs in secure communications technology. All content is verified through primary sources to ensure accuracy for financial decision-making.
Bookmark this page for centralized access to Leidos' latest achievements in supporting national security infrastructure and advancing critical healthcare systems through technological innovation.
On August 3, 2020, Leidos announced the appointment of Elizabeth Porter as Health Group President, effective immediately. Reporting to Chairman and CEO Roger Krone, Porter will oversee a $2 billion business with 7,500 employees focused on transforming patient care and healthcare operations. She has been acting president since March 9, and her experience includes leadership roles at Lockheed Martin. Krone emphasized her strong track record in driving growth, noting her expertise will be crucial as the health market evolves.
Leidos Holdings (NYSE: LDOS) has declared a quarterly cash dividend of $0.34 per share. This dividend will be paid on September 30, 2020, to shareholders of record by September 15, 2020. Leidos, a leader in information technology and engineering solutions, reported annual revenues of approximately $11.09 billion for the fiscal year ending January 3, 2020.
Leidos (NYSE: LDOS), a leading science and technology firm, will participate in the Jefferies 2020 Virtual Industrials Conference on August 6, 2020, featuring a fireside chat led by Chairman and CEO Roger Krone at 1:15 p.m. ET. The event will be available via a live audio webcast on Leidos' Investor Relations website, with a replay accessible for 30 days post-event. Leidos reported annual revenues of approximately $11.09 billion for the fiscal year ending January 3, 2020, employing around 37,000 personnel to tackle significant challenges across various sectors.
Leidos (NYSE:LDOS) announced that 18 employees will be recognized at the 2020 Women of Color STEM conference in Detroit, marking the largest cohort in the company's history. Regina Cer and Audrey Lambert will receive the Technology Rising Star award, while others like Stephanie Alley and Rita Chavez will be honored with the Technology All-Star award. Additionally, Dr. Carol Brevett will receive the Outstanding Technical Contribution award. Leidos emphasizes its commitment to diversity and inclusion, highlighting the contributions of women in STEM fields.
Leidos (NYSE:LDOS) has secured a contract from U.S. Customs and Border Protection to implement a non-intrusive inspection system for high-energy rail infrastructure. This contract, valued at approximately $379 million, spans an ordering period of five years starting July 1, 2020. Leidos will utilize its VACIS IR6500 system, enhancing threat detection capabilities significantly. The technology aims to improve efficiency in screening $180 billion worth of rail freight annually, thereby aiding in the prevention of contraband smuggling into the U.S.
Leidos (NYSE:LDOS) has secured a task order from the U.S. Army Contracting Command valued at approximately $210 million for providing Intelligence, Electronic Warfare and Sensors (IEW&S) system and software support. The contract includes a one-year base period with four additional one-year options. The work will primarily occur at Aberdeen Proving Ground, Md. Under this contract, Leidos will enhance the reliability and interoperability of the Army's systems through its agile software development process and portfolio management dashboard.
Leidos (NYSE: LDOS) has scheduled a conference call for August 4, 2020, at 8 a.m. (ET) to discuss its second-quarter financial results for the period ending July 3, 2020. The earnings press release will precede the call on the same day. Investors can listen via the internet or telephone, and a replay will be available from 11:30 a.m. (ET) on August 4 through 11:59 p.m. (ET) on August 11, 2020. Leidos reported $11.09 billion in annual revenues for fiscal year ending January 3, 2020.
Leidos (NYSE:LDOS) has secured a prime contract with Edinburgh Airport Limited to enhance its security tray systems by implementing antimicrobial technology. This technology reduces bacteria like E. coli and MRSA by 99.99%, addressing health concerns amid the ongoing pandemic. Leidos has collaborated with Edinburgh Airport since 2012 and aims to support improved health safety for travelers. The company reported revenues of approximately $11.09 billion for the fiscal year ending January 3, 2020, and has a strong portfolio of security detection solutions deployed in over 120 countries.
Leidos (NYSE:LDOS) has secured a $79 million contract from the Department of Veterans Affairs to design and implement a regional consolidated mail outpatient pharmacy system (CMOP). The contract includes a two-year performance period with 20 additional three-month options. Leidos aims to replace the existing facility in Leavenworth, Kansas, establishing a highly automated pharmacy capable of processing over 80,000 prescriptions daily. This initiative supports the VA's modernization efforts and enhances service to U.S. military veterans.
Leidos (NYSE: LDOS) and the Baltimore Ravens are distributing nearly 70,000 drug disposal packets across Baltimore as part of the "Tackling Opioid Addiction" campaign. This initiative aims to combat the opioid epidemic, which has escalated during the COVID-19 pandemic, with over 90% of drug-related deaths in Baltimore being opioid-related. The packets will allow residents to safely dispose of leftover prescriptions at home. Leidos has maintained a commitment to addressing opioid addiction since 2017, implementing several community-driven initiatives.